Pediatric transplants | Adult transplants | |
---|---|---|
Characteristic | (n =192) | (n =990) |
Age (yr) – median (IQR) | 11 (6, 15) | 52 (42, 61) |
Sex: male – n (%) | 104 (54) | 583 (59) |
Race/Ethnicity – n (%) | ||
Caucasian | 101 (53) | 761 (77) |
Hispanic | 31 (17) | 27 (3) |
Asian Pacific-Islander | 19 (10) | 59 (6) |
Black | 6 (3) | 17 (2) |
Native American | 2 (1) | 8 (1) |
Other | 22 (12) | 53 (5) |
Unknown | 11 (6) | 65 (7) |
Underlying Disease – n (%) | ||
ALL | 67 (35) | 107 (11) |
AML | 34 (18) | 341 (34) |
MDS | 12 (6) | 206 (21) |
NHL | 7 (4) | 107 (11) |
CML | 6 (3) | 36 (4) |
HD | 1 (1) | 30 (3) |
Other | 65 (34) | 163 (17) |
Stem cell source – n (%) | ||
Bone marrow | 102 (53) | 155 (16) |
PBSC | 36 (19) | 743 (75) |
Cord blood | 54 (28) | 92 (9) |
Donor – n (%) | ||
Sibling | 52 (27) | 300 (30) |
Unrelated | 80 (42) | 523 (53) |
Cord | 54 (28) | 92 (9) |
Haploidentical | 6 (3) | 68 (7) |
Conditioning regimen – n (%) | ||
Myeloablative | 175 (91) | 559 (57) |
Nonmyeloablative | 17 (9) | 431 (44) |
GVHD prophylaxis – n (%) | ||
CSP or FK506, with MTX | 106 (55) | 360 (36) |
MMF regimen | 74 (39) | 539 (54) |
Other/none | 12 (6) | 91 (9) |
Inpatient daysa – median (IQR) | 41 (31, 55) | 18 (5, 28) |